CORE--ANIMAL PROCEDURES
核心——动物程序
基本信息
- 批准号:7100664
- 负责人:
- 金额:$ 6.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-12-01 至 2009-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The goal of the Animal Procedures Core Facility is to provide a central facility staffed by two skilled individuals to promote reproducible experimentation in laboratory animals. Services include drug screening, tumorigenicity testing and reagent production and small animal colony management. The Core is led by Dr. Bernard Weissman and Ms. Natalie Edmunds. The Core adds value to the Center by providing the animal tumor model expertise lacking in most laboratories, reducing the overall cost of such studies, ensuring a high level of reproducibility for animal studies and fostering interactions between Cancer Center members. Highlights of research supported by the Core include: highly-skilled maneuvers to characterize novel antineoplastic
reagents including: intra-tibial inoculations, oral garage, and new treatments of NPC tumors with
adenoviral reagents. Future plans for the Core include the addition of new Cancer Center users, expansion of colony management services including genotyping in conjunction with the Animal Models Core Facility and integration of small animal imaging with the new Small Animal Imaging Core Facility.
动物程序核心设施的目标是提供一个由两名熟练人员组成的中心设施,以促进实验室动物的可重复实验。服务包括药物筛查、致瘤性检测、试剂生产和小动物群体管理。核心由伯纳德·韦斯曼博士和娜塔莉·埃德蒙兹女士领导。核心通过提供大多数实验室缺乏的动物肿瘤模型专业知识,降低此类研究的总体成本,确保动物研究的高水平再现性,并促进癌症中心成员之间的互动,为中心增加了价值。核心支持的研究重点包括:
试剂,包括:胫骨内接种,口服车库,和新的治疗NPC肿瘤,
腺病毒试剂。 核心的未来计划包括增加新的癌症中心用户,扩大菌落管理服务,包括与动物模型核心设施一起进行基因分型,以及将小动物成像与新的小动物成像核心设施整合。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bernard E. Weissman其他文献
Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type
超级增强子与雷公藤甲素在卵巢高钙血症型小细胞癌中的疗效
- DOI:
10.1016/j.isci.2025.111770 - 发表时间:
2025-02-21 - 期刊:
- 影响因子:4.100
- 作者:
Jessica D. Lang;William Selleck;Shawn Striker;Nicolle A. Hipschman;Rochelle Kofman;Anthony N. Karnezis;Felix K.F. Kommoss;Friedrich Kommoss;Jae Rim Wendt;Salvatore J. Facista;William P.D. Hendricks;Krystal A. Orlando;Patrick Pirrotte;Elizabeth A. Raupach;Victoria L. Zismann;Yemin Wang;David G. Huntsman;Bernard E. Weissman;Jeffrey M. Trent - 通讯作者:
Jeffrey M. Trent
Mutant Nrf2supE79Q/sup enhances the promotion and progression of a subset of oncogenic Ras keratinocytes and skin tumors
突变的NRF2SUPE79Q/SUP增强了致癌性Ras角质形成细胞和皮肤肿瘤的促进和进展
- DOI:
10.1016/j.redox.2024.103261 - 发表时间:
2024-09-01 - 期刊:
- 影响因子:11.900
- 作者:
John G. Witherspoon;Jonathan R. Hall;Dereje Jima;Hannah M. Atkins;Nathan T. Wamsley;Michael B. Major;Bernard E. Weissman;Robert C. Smart - 通讯作者:
Robert C. Smart
SNF5/INI1 Deficiency Destabilizes the SWI/SNF Complex During Malignant Rhabdoid Tumor Development
- DOI:
10.1016/j.cancergen.2014.09.007 - 发表时间:
2014-09-01 - 期刊:
- 影响因子:
- 作者:
Yasumichi Kuwahara;Darmood Wei;Shujie Song;Courtney Cannon;Donastas Sakellariou-Thompson;Michael Emanuele;Hajime Hosoi;Bernard E. Weissman - 通讯作者:
Bernard E. Weissman
Bernard E. Weissman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bernard E. Weissman', 18)}}的其他基金
Role of hsnf5/BAF47 Loss in Human Cancer Development
hsnf5/BAF47 缺失在人类癌症发展中的作用
- 批准号:
8322896 - 财政年份:2011
- 资助金额:
$ 6.28万 - 项目类别:
SWI/SNF complex loss facilitates gene silencing during NSCLC development
SWI/SNF 复合物丢失促进 NSCLC 发展过程中的基因沉默
- 批准号:
7635080 - 财政年份:2009
- 资助金额:
$ 6.28万 - 项目类别:
SWI/SNF Chromatin Remodeling Loss and Human Cancer
SWI/SNF 染色质重塑损失与人类癌症
- 批准号:
6681590 - 财政年份:2003
- 资助金额:
$ 6.28万 - 项目类别:
SWI/SNF Chromatin Remodeling Loss and Human Cancer
SWI/SNF 染色质重塑损失与人类癌症
- 批准号:
6790490 - 财政年份:2003
- 资助金额:
$ 6.28万 - 项目类别:
SWI/SNF Chromatin Remodeling Loss and Human Cancer
SWI/SNF 染色质重塑损失与人类癌症
- 批准号:
7098021 - 财政年份:2003
- 资助金额:
$ 6.28万 - 项目类别:
SWI/SNF Chromatin Remodeling Loss and Human Cancer
SWI/SNF 染色质重塑损失与人类癌症
- 批准号:
7267012 - 财政年份:2003
- 资助金额:
$ 6.28万 - 项目类别: